The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTissue Regenix Group Regulatory News (TRX)

Share Price Information for Tissue Regenix Group (TRX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 61.50
Bid: 61.00
Ask: 62.00
Change: -0.50 (-0.81%)
Spread: 1.00 (1.639%)
Open: 61.50
High: 61.00
Low: 61.00
Prev. Close: 61.50
TRX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

18 Aug 2022 14:10

RNS Number : 5137W
Tissue Regenix Group PLC
18 August 2022
 

TR-1: Standard form for notification of major holdings

1. Issuer Details

ISIN

GB00B5SGVL29

Issuer Name

TISSUE REGENIX GROUP PLC

UK or Non-UK Issuer

UK

2. Reason for Notification

An acquisition or disposal of voting rights

3. Details of person subject to the notification obligation

Name

Harwood Capital Management (Gibraltar) Limited

City of registered office (if applicable)

Gibraltar

Country of registered office (if applicable)

Gibraltar

Name

City of registered office

Country of registered office

Harwood Capital LLP

London

United Kingdom

4. Details of the shareholder

Name

City of registered office

Country of registered office

Oryx International Growth Fund Limited

St Peter Port

Guernsey

Harwood Capital LLP

London

United Kingdom

5. Date on which the threshold was crossed or reached

17-Aug-2022

6. Date on which Issuer notified

18-Aug-2022

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8.A)

% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights held in issuer

Resulting situation on the date on which threshold was crossed or reached

15.530000

0.000000

15.530000

1092322756

Position of previous notification (if applicable)

16.240000

0.000000

16.240000

1142322756

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached

8A. Voting rights attached to shares

Class/Type of shares ISIN code(if possible)

Number of direct voting rights (DTR5.1)

Number of indirect voting rights (DTR5.2.1)

% of direct voting rights (DTR5.1)

% of indirect voting rights (DTR5.2.1)

GB00BM4NR742

750000000

10.660000

GB00BM4NR742

342322756

4.870000

Sub Total 8.A

1092322756

15.530000%

8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))

Type of financial instrument

Expiration date

Exercise/conversion period

Number of voting rights that may be acquired if the instrument is exercised/converted

% of voting rights

 

Sub Total 8.B1

8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))

Type of financial instrument

Expiration date

Exercise/conversion period

Physical or cash settlement

Number of voting rights

% of voting rights

 

Sub Total 8.B2

9. Information in relation to the person subject to the notification obligation

2. Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entities (please add additional rows as necessary)

Ultimate controlling person

Name of controlled undertaking

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

Christopher Harwood Bernard Mills

Harwood Capital LLP

4.870000

4.870000%

Christopher Harwood Bernard Mills

Oryx International Growth Fund Limited

10.660000

10.660000%

10. In case of proxy voting

Name of the proxy holder

 

The number and % of voting rights held

 

The date until which the voting rights will be held

 

11. Additional Information

 

12. Date of Completion

18-Aug-2022

13. Place Of Completion

London Stock Exchange

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
HOLUWRORUKUWAAR
Date   Source Headline
23rd Nov 20105:18 pmRNSIssue of Equity
20th Oct 20107:00 amRNSHalf Yearly Report
18th Aug 20102:19 pmRNSHolding(s) in Company
10th Aug 20107:00 amRNSCE Mark Grant
5th Aug 20103:43 pmRNSPatents approved
1st Jul 201010:38 amRNSHolding(s) in Company
29th Jun 20104:37 pmRNSIssue of Equity
29th Jun 20108:06 amRNSFirst day dealings in Tissue Regenix
29th Jun 20107:00 amRNSFirst Day of Dealings
28th Jun 20102:20 pmRNSResult of General Meeting
10th Jun 20103:39 pmRNSSch 1 - Oxeco (to be renamed Tissue Regenix Group)
3rd Jun 20107:00 amRNSAcquisition
21st Apr 201011:20 amRNSResult of AGM
26th Mar 20107:00 amRNSFinal Results
11th Jan 20105:05 pmRNSHolding(s) in Company
23rd Dec 20091:49 pmRNSHolding(s) in Company
23rd Dec 200912:07 pmRNSHolding(s) in Company
22nd Dec 20094:33 pmRNSHolding(s) in Company
17th Dec 20093:50 pmRNSHolding(s) in Company
17th Dec 20092:47 pmRNSHolding(s) in Company
9th Dec 20099:28 amRNSInvesting Policy
23rd Oct 20097:00 amRNSInterim financial report
25th Aug 20092:30 pmRNSHolding(s) in Company
23rd Jul 20097:00 amRNSClosure of subsidiary business
2nd Jun 200912:00 pmRNSAppointment of Non-Executive Director
26th May 20093:00 pmRNSChange of Nominated Adviser Name
20th Apr 20097:00 amRNSFinal Results
24th Mar 200910:18 amRNSAppointment of Broker
18th Mar 200911:54 amRNSStrategic Review and Directorate Change
19th Nov 20087:00 amRNSDirectorate Change
16th Oct 20087:00 amRNSInterim Results
9th Jul 200812:39 pmRNSHolding(s) in Company
29th May 200812:10 pmRNSAGM Statement
30th Apr 20085:27 pmRNSAudited Final Results
28th Sep 20077:04 amRNSInterim Results
17th Aug 20077:01 amRNSAIM Rule 26 Website
29th Jun 20079:00 amRNSTotal Voting Rights
29th Jun 20078:00 amRNSAccounts to 31 January 2007
29th Jun 20078:00 amRNSAppointment of Directors
25th Jun 20071:38 pmRNSEGM Statement
20th Jun 20077:01 amRNSDisposal & Administration
14th Jun 20074:23 pmRNSRule 8.3- Torex Retail-Amend
13th Jun 20075:34 pmRNSRule 8.3-Torex Retail CB 5.5%
7th Jun 20072:11 pmRNSNotice of EGM
1st Jun 20077:01 amRNSBoard change
17th May 20073:58 pmRNSReview of strategic options
13th Apr 20073:33 pmRNSRule 8.3- Torex Retail Plc
3rd Apr 20072:28 pmRNSRule 2.10 Announcement
30th Mar 20075:03 pmRNSStrategic Review
27th Mar 20075:20 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.